Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells
Hsiang Ju Chen
, Rui Lan Huang
,
Phui Ly Liew
, Po Hsuan Su
, Lin Yu Chen
, Yu Chun Weng
, Cheng Chang Chang
, Yu Chi Wang
, Michael Wing Yan Chan
,
Hung Cheng Lai
Taipei Medical University Shuang Ho Hospital
Department of Pathology
TMU Research Center of Cell Therapy and Regeneration Medicine
Department of Obstetrics and Gynecology
International Master/Ph.D. Program in Medicine
TMU Research Center of Cancer Translational Medicine
International Ph.D. Program in Cell Therapy and Regenerative Medicine
Graduate Institute of Clinical Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
30
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Stem Cell
100%
Serous Carcinoma
100%
Transcription Factor GATA 3
100%
Biological Marker
14%
Recurrent Disease
14%
Malignant Neoplasm
14%
Cancer Stem Cell
14%
Cancer
14%
Cancer Cell
14%
Programmed Cell Death
14%
Gemcitabine
14%
Carcinoma Cell Line
14%
Epigenetic Therapy
14%
Drug Resistance
14%
Cytotoxicity
14%
Progenitor Cell
14%
Paclitaxel
14%
Transcriptome
14%
Histone H3
14%
Lysine
14%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
GATA3
100%
Cancer Cell
14%
Lysine
14%
Gemcitabine
14%
Demethylase
14%
Epigenetic Therapy
14%
Drug Resistance
14%
Cancer Stem Cell
14%
Cytotoxicity
14%
Progenitor Cell
14%
Transcriptome
14%
Histone H3
14%